{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:07:05Z","timestamp":1794852425275,"version":"4.9.1"},"reference-count":45,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:p>Dexamethasone, a long-acting potent glucocorticoid, is one of the most widely used medications in neurosurgery. In this paper, the authors recount the history of dexamethasone\u2019s rise in neurosurgery and discuss its use in brain tumors in the context of emerging neuro-oncological immunotherapies. In 1958, Glen E. Arth synthesized a 16-alpha-methylated analog of cortisone (dexamethasone) for treatment of rheumatoid arthritis. Joseph Galicich, a neurosurgery resident at the time, applied the rheumatological drug to neurosurgery. He gave doses to patients who had undergone craniotomy for tumor removal and saw their paresis improve, midline shift resolve, and mortality rates decrease. He advocated for clinical trials and the drug became a mainstay in neurosurgery. As neuro-oncological treatments evolve to include immunotherapy, the immunosuppressive effects of dexamethasone are becoming an unwanted effect. The question then becomes: how does one treat the patient\u2019s symptoms if the only drug that has been used throughout history may become a detriment to their oncological treatment? Since its discovery, dexamethasone has maintained an impressive staying power in the field, acting as a standard drug for cerebral edema for more than 60 years. However, with the advent of immunotherapy, research is warranted to evaluate ways of treating symptomatic edema in the context of modern neuro-oncological therapies.<\/jats:p>","DOI":"10.3171\/2023.9.jns231099","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T20:29:25Z","timestamp":1700857765000},"page":"1191-1197","source":"Crossref","is-referenced-by-count":17,"title":["The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery"],"prefix":"10.3171","volume":"140","author":[{"given":"Sima","family":"Vazquez","sequence":"first","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Gold","sequence":"additional","affiliation":[{"name":"School of Medicine, Cooper Medical School of Rowan University, Camden, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eris","family":"Spirollari","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Akmal","sequence":"additional","affiliation":[{"name":"School of Medicine, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hanft","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Westchester Medical Center, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","article-title":"World Health Organization Model List of Essential Medicines\u201422nd list, 2021","unstructured":"World Health Organization. World Health Organization Model List of Essential Medicines\u201422nd list, 2021. Published September 30, 2021. Accessed October 9, 2023.https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02"},{"key":"b2","series-title":"J Control Release","first-page":"179","article-title":"Dexamethasone palmitate nanoparticles: an efficient treatment for rheumatoid arthritis","volume":"296","author":"Lorscheider M","year":"2019","unstructured":"Lorscheider M, Tsapis N, Ur-Rehman M,  Dexamethasone palmitate nanoparticles: an efficient treatment for rheumatoid arthritis. J Control Release. 2019;296:179\u2013189."},{"issue":"3","key":"b3","series-title":"Pediatrics","first-page":"493","article-title":"Dexamethasone for acute asthma exacerbations in children: a meta-analysis","volume":"133","author":"Keeney GE","year":"2014","unstructured":"Keeney GE, Gray MP, Morrison AK,  Dexamethasone for acute asthma exacerbations in children: a meta-analysis. Pediatrics. 2014;133(3):493\u2013499."},{"issue":"9","key":"b4","series-title":"Support Care Cancer","first-page":"7689","article-title":"Dexamethasone prescribing for cancer pain between palliative care and radiation oncology","volume":"30","author":"Jeong A","year":"2022","unstructured":"Jeong A, Wade K. Dexamethasone prescribing for cancer pain between palliative care and radiation oncology. Support Care Cancer. 2022;30(9):7689\u20137696."},{"key":"b5","series-title":"Am Pract Dig Treat","first-page":"169","article-title":"Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery","volume":"12","author":"Galicich JH","year":"1961","unstructured":"Galicich JH, French LA. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat. 1961;12:169\u2013174."},{"issue":"2","key":"b6","series-title":"Expert Rev Clin Pharmacol","first-page":"233","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich J","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011;4(2):233\u2013242."},{"issue":"8","key":"b7","series-title":"Proc Staff Meet Mayo Clin","first-page":"181","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench PS","year":"1949","unstructured":"Hench PS, Kendall EC, Slocumb C, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin. 1949;24(8):181\u2013197."},{"issue":"12","key":"b8","series-title":"J Am Chem Soc","first-page":"3160","article-title":"16-Methylated steroids. I. 16\u03b1-Methylated analogs of cortisone, a new group of anti-inflammatory steroids","volume":"80","author":"Arth GE","year":"1958","unstructured":"Arth GE, Johnston DBR, Fried J, Spooncer WW, Hoff DR, Sarett LH. 16-Methylated steroids. I. 16\u03b1-Methylated analogs of cortisone, a new group of anti-inflammatory steroids. J Am Chem Soc. 1958;80(12):3160\u20133161."},{"issue":"16","key":"b9","series-title":"J Am Chem Soc","first-page":"4431","article-title":"16-Alkylated corticoids. II. 9\u03b1-Fluoro-16\u03b1-methylprednisolone 21-acetate","volume":"80","author":"Oliveto EP","year":"1958","unstructured":"Oliveto EP, Rausser R, Weber L,  16-Alkylated corticoids. II. 9\u03b1-Fluoro-16\u03b1-methylprednisolone 21-acetate. J Am Chem Soc. 1958;80(16):4431."},{"issue":"7","key":"b10","series-title":"Can Fam Physician","first-page":"704","article-title":"Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients","volume":"55","author":"Shefrin AE","year":"2009","unstructured":"Shefrin AE, Goldman RD. Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients. Can Fam Physician. 2009;55(7):704\u2013706."},{"issue":"9","key":"b11","series-title":"Can Med Assoc J","first-page":"928","article-title":"\"Compendium of pharmaceuticals and specialties.\"","volume":"129","author":"Krogh C","year":"1983","unstructured":"Krogh C. \"Compendium of pharmaceuticals and specialties.\". Can Med Assoc J. 1983;129(9):928."},{"issue":"2","key":"b12","series-title":"Am Fam Physician","first-page":"443","article-title":"A different look at corticosteroids","volume":"58","author":"Zoorob RJ","year":"1998","unstructured":"Zoorob RJ, Cender D. A different look at corticosteroids. Am Fam Physician. 1998;58(2):443\u2013450."},{"issue":"3","key":"b13","series-title":"DICP","first-page":"229","article-title":"Characterization of dexamethasone binding in normal and uremic human serum","volume":"24","author":"Cummings DM","year":"1990","unstructured":"Cummings DM, Larijani GE, Conner DP, Ferguson RK, Rocci ML Jr. Characterization of dexamethasone binding in normal and uremic human serum. DICP. 1990;24(3):229\u2013231."},{"issue":"suppl 1","key":"b14","series-title":"Clin Pharmacokinet","first-page":"10","article-title":"Protein binding and drug clearance","volume":"9","author":"Rowland M","year":"1984","unstructured":"Rowland M. Protein binding and drug clearance. Clin Pharmacokinet. 1984;9(suppl 1):10\u201317."},{"key":"b15","series-title":"StatPearls [Internet]","article-title":"Dexamethasone suppression test","author":"Dogra P","year":"2023","unstructured":"Dogra P, Vijayashankar NP. Dexamethasone suppression test. In: StatPearls [Internet]. StatPearls Publishing; 2023. Accessed October 9, 2023.http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542317\/"},{"issue":"1","key":"b16","series-title":"Allergy Asthma Clin Immunol","first-page":"30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu D","year":"2013","unstructured":"Liu D, Ahmet A, Ward L,  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30."},{"issue":"4","key":"b17","series-title":"Arthritis Rheum","first-page":"313","article-title":"Studies on dexamethasone, a new synthetic steroid, in rheumatoid arthritis\u2014a preliminary report","volume":"1","author":"Bunim JJ","year":"1958","unstructured":"Bunim JJ, Black RL, Lutwak L, Peterson RE, Whedon GD. Studies on dexamethasone, a new synthetic steroid, in rheumatoid arthritis\u2014a preliminary report. Arthritis Rheum. 1958;1(4):313\u2013331."},{"key":"b18","series-title":"Arthritis Rheum","first-page":"112","article-title":"Dexamethasone: antirheumatic properties, hormonal effects and adverse reactions (a 16 month study)","volume":"3","author":"Black RL","year":"1960","unstructured":"Black RL, Reefe WE, David JR, Bloch KJ, Ehrlich GE, Bunim JJ. Dexamethasone: antirheumatic properties, hormonal effects and adverse reactions (a 16 month study). Arthritis Rheum. 1960;3:112\u2013128."},{"issue":"4","key":"b19","series-title":"Calif Med","first-page":"262","article-title":"Effectiveness of antacids in reducing digestive disturbances in patients treated with prednisone and prednisolone","volume":"89","author":"Boland EW","year":"1958","unstructured":"Boland EW. Effectiveness of antacids in reducing digestive disturbances in patients treated with prednisone and prednisolone. Calif Med. 1958;89(4):262\u2013266."},{"key":"b20","series-title":"Arch Neurol Psychiatry","first-page":"163","article-title":"Studies on cerebral edema; reaction of the brain to air exposure; pathologic changes","volume":"54","author":"Prados M","year":"1945","unstructured":"Prados M, Strowger B, Feindel WH. Studies on cerebral edema; reaction of the brain to air exposure; pathologic changes. Arch Neurol Psychiatry. 1945;54:163\u2013174."},{"issue":"6","key":"b21","series-title":"J Neurosurg","first-page":"508","article-title":"Central nervous system resistance; the effect of adrenal cortical substances on the central nervous system","volume":"4","author":"Grenell RG","year":"1947","unstructured":"Grenell RG, McCawley EL. Central nervous system resistance; the effect of adrenal cortical substances on the central nervous system. J Neurosurg. 1947;4(6):508\u2013518."},{"issue":"15","key":"b22","series-title":"N Engl J Med","first-page":"568","article-title":"Cortisone and ACTH as an adjunct to the surgery of craniopharyngiomas","volume":"246","author":"Ingraham FD","year":"1952","unstructured":"Ingraham FD, Matson DD, McLaurin RL. Cortisone and ACTH as an adjunct to the surgery of craniopharyngiomas. N Engl J Med. 1952;246(15):568\u2013571."},{"issue":"6","key":"b23","series-title":"J Neurosurg","first-page":"555","article-title":"Cortisone as an aid in the surgical treatment of craniopharyngiomas","volume":"12","author":"Tytus JS","year":"1955","unstructured":"Tytus JS, Seltzer HS, Kahn EA. Cortisone as an aid in the surgical treatment of craniopharyngiomas. J Neurosurg. 1955;12(6):555\u2013564."},{"issue":"4","key":"b24","series-title":"J Am Geriatr Soc","first-page":"216","article-title":"Cortisone in the immediate therapy of apoplectic stroke","volume":"2","author":"Russek HI","year":"1954","unstructured":"Russek HI, Zohman BL, Russek AS. Cortisone in the immediate therapy of apoplectic stroke. J Am Geriatr Soc. 1954;2(4):216\u2013222."},{"issue":"16","key":"b25","series-title":"J Am Med Assoc","first-page":"1473","article-title":"Treatment of cerebral metastases from breast carcinoma with prednisolone","volume":"163","author":"Kofman S","year":"1957","unstructured":"Kofman S, Garvin JS, Nagamani D, Taylor SG III. Treatment of cerebral metastases from breast carcinoma with prednisolone. J Am Med Assoc. 1957;163(16):1473\u20131476."},{"key":"b26","series-title":"J Lancet","first-page":"46","article-title":"Use of dexamethasone in treatment of cerebral edema associated with brain tumors","volume":"81","author":"Galicich JH","year":"1961","unstructured":"Galicich JH, French LA, Melby JC. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. J Lancet. 1961;81:46\u201353."},{"issue":"6","key":"b27","series-title":"Curr Opin Oncol","first-page":"593","article-title":"The management of brain edema in brain tumors","volume":"16","author":"Kaal ECA","year":"2004","unstructured":"Kaal ECA, Vecht CJ. The management of brain edema in brain tumors. Curr Opin Oncol. 2004;16(6):593\u2013600."},{"issue":"5","key":"b28","series-title":"Neurosurg Focus","first-page":"E8","article-title":"Mechanisms of tumor-related brain edema","volume":"22","author":"Stummer W","year":"2007","unstructured":"Stummer W. Mechanisms of tumor-related brain edema. Neurosurg Focus. 2007;22(5):E8."},{"issue":"suppl 1","key":"b29","series-title":"Clin Neurosurg","first-page":"212","article-title":"The use of steroids for control of cerebral edema","volume":"10","author":"French LA","year":"1964","unstructured":"French LA, Galicich JH. The use of steroids for control of cerebral edema. Clin Neurosurg. 1964;10(suppl 1):212-223."},{"issue":"1","key":"b30","series-title":"Eur J Cancer","first-page":"22","article-title":"Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial","volume":"30A","author":"S\u00f8rensen S","year":"1994","unstructured":"S\u00f8rensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer. 1994;30A(1):22-27."},{"issue":"3","key":"b31","series-title":"Neurosurgery","first-page":"E189","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors","volume":"84","author":"Ryken TC","year":"2019","unstructured":"Ryken TC, Kuo JS, Prabhu RS, Sherman JH, Kalkanis SN, Olson JJ. Congress of Neurological Surgeons systematic review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors. Neurosurgery. 2019;84(3):E189\u2013E191."},{"issue":"8","key":"b32","series-title":"N Engl J Med","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR,  Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704."},{"issue":"8","key":"b33","series-title":"Am J Hematol","first-page":"1086","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086\u20131107."},{"issue":"3","key":"b34","series-title":"J Neurosurg Anesthesiol","first-page":"220","article-title":"Higher dose dexamethasone increases early postoperative cognitive dysfunction","volume":"26","author":"Fang Q","year":"2014","unstructured":"Fang Q, Qian X, An J, Wen H, Cope DK, Williams JP. Higher dose dexamethasone increases early postoperative cognitive dysfunction. J Neurosurg Anesthesiol. 2014;26(3):220\u2013225."},{"issue":"2","key":"b35","series-title":"J Neurosurg Anesthesiol","first-page":"150","article-title":"A randomized controlled trial studying the role of dexamethasone in scalp nerve blocks for supratentorial craniotomy","volume":"29","author":"Jose R","year":"2017","unstructured":"Jose R, Chakravarthy K, Nair S, Joseph M, Jeyaseelan V, Korula G. A randomized controlled trial studying the role of dexamethasone in scalp nerve blocks for supratentorial craniotomy. J Neurosurg Anesthesiol. 2017;29(2):150\u2013156."},{"issue":"5","key":"b36","series-title":"Otol Neurotol","first-page":"616","article-title":"Endolymphatic sac decompression with intra-sac dexamethasone injection in Meni\u00e8re\u2019s disease","volume":"39","author":"Bojrab DI II","year":"2018","unstructured":"Bojrab DI II, LaRouere MJ, Bojrab DI,  Endolymphatic sac decompression with intra-sac dexamethasone injection in Meni\u00e8re\u2019s disease. Otol Neurotol. 2018;39(5):616\u2013621."},{"key":"b37","series-title":"J Clin Neurosci","first-page":"153","article-title":"Prospective randomized placebo-controlled double-blind clinical study of adjuvant dexamethasone with surgery for chronic subdural haematoma with post-operative subdural drainage: interim analysis","volume":"71","author":"Mebberson K","year":"2020","unstructured":"Mebberson K, Colditz M, Marshman LAG, Thomas PAW, Mitchell PS, Robertson K. Prospective randomized placebo-controlled double-blind clinical study of adjuvant dexamethasone with surgery for chronic subdural haematoma with post-operative subdural drainage: interim analysis. J Clin Neurosci. 2020;71:153\u2013157."},{"issue":"6","key":"b38","series-title":"Paediatr Anaesth","first-page":"665","article-title":"Dexamethasone as a ropivacaine adjuvant to pre-emptive incision-site infiltration analgesia in pediatric craniotomy patients: a prospective, multicenter, randomized, double-blind, controlled trial","volume":"31","author":"Zhao C","year":"2021","unstructured":"Zhao C, Zhang N, Shrestha N, Liu H, Ge M, Luo F. Dexamethasone as a ropivacaine adjuvant to pre-emptive incision-site infiltration analgesia in pediatric craniotomy patients: a prospective, multicenter, randomized, double-blind, controlled trial. Paediatr Anaesth. 2021;31(6):665\u2013675."},{"key":"b39","series-title":"World Neurosurg","first-page":"1","article-title":"Updated review: the steroid controversy for management of spinal cord injury","volume":"150","author":"Canseco JA","year":"2021","unstructured":"Canseco JA, Karamian BA, Bowles DR,  Updated review: the steroid controversy for management of spinal cord injury. World Neurosurg. 2021;150:1\u20138."},{"issue":"1","key":"b40","series-title":"Clin Cancer Res","first-page":"276","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu JB","year":"2021","unstructured":"Iorgulescu JB, Gokhale PC, Speranza MC,  Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma. Clin Cancer Res. 2021;27(1):276\u2013287."},{"key":"b41","article-title":"National Cancer Institute. Steroids May Limit the Effectiveness of Immunotherapy for Brain Cancer","year":"2020","unstructured":"National Cancer Institute. Steroids May Limit the Effectiveness of Immunotherapy for Brain Cancer. Published December 28,2020. Accessed October 9, 2023.https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2020\/brain-cancer-immunotherapy-steroids-limit-effectiveness"},{"issue":"505","key":"b42","series-title":"Sci Transl Med","first-page":"eaaw5680","article-title":"Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: results of a phase 1 trial","volume":"11","author":"Chiocca EA","year":"2019","unstructured":"Chiocca EA, Yu JS, Lukas RV,  Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: results of a phase 1 trial. Sci Transl Med. 2019;11(505):eaaw5680."},{"issue":"1","key":"b43","series-title":"J Immunother Cancer","first-page":"51","article-title":"Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy","volume":"6","author":"Giles AJ","year":"2018","unstructured":"Giles AJ, Hutchinson MND, Sonnemann HM,  Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018;6(1):51."},{"issue":"2","key":"b44","series-title":"Expert Opin Emerg Drugs","first-page":"137","article-title":"Update on bevacizumab and other angiogenesis inhibitors for brain cancer","volume":"18","author":"Rinne ML","year":"2013","unstructured":"Rinne ML, Lee EQ, Nayak L,  Update on bevacizumab and other angiogenesis inhibitors for brain cancer. Expert Opin Emerg Drugs. 2013;18(2):137\u2013153."},{"issue":"2","key":"b45","series-title":"Neurotherapeutics","first-page":"635","article-title":"RAGE inhibitors as alternatives to dexamethasone for managing cerebral edema following brain tumor surgery","volume":"19","author":"Liu S","year":"2022","unstructured":"Liu S, Song Y, Zhang IY,  RAGE inhibitors as alternatives to dexamethasone for managing cerebral edema following brain tumor surgery. Neurotherapeutics. 2022;19(2):635\u2013648."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/140\/4\/article-p1191.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/140\/4\/article-p1191.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/140\/4\/article-p1191.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:20:19Z","timestamp":1716618019000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/140\/4\/article-p1191.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":45,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2023.9.jns231099","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}